126 related articles for article (PubMed ID: 25603020)
1. Silibinin affects tumor cell growth because of reduction of stemness properties and induction of apoptosis in 2D and 3D models of MDA-MB-468.
Abdollahi P; Ebrahimi M; Motamed N; Samani FS
Anticancer Drugs; 2015 Jun; 26(5):487-97. PubMed ID: 25603020
[TBL] [Abstract][Full Text] [Related]
2. Comparative Evaluation of Silibinin Effects on Cell Cycling and Apoptosis in Human Breast Cancer MCF-7 and T47D Cell Lines.
Jahanafrooz Z; Motameh N; Bakhshandeh B
Asian Pac J Cancer Prev; 2016; 17(5):2661-5. PubMed ID: 27268647
[TBL] [Abstract][Full Text] [Related]
3. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.
Yazdi Rouholamini SE; Moghassemi S; Maharat Z; Hakamivala A; Kashanian S; Omidfar K
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):524-535. PubMed ID: 28509572
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
5. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
[TBL] [Abstract][Full Text] [Related]
6. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
Tyagi AK; Agarwal C; Chan DC; Agarwal R
Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
[TBL] [Abstract][Full Text] [Related]
7. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
Kim TH; Woo JS; Kim YK; Kim KH
J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
[TBL] [Abstract][Full Text] [Related]
8. Silibinin induces apoptosis and inhibits proliferation of estrogen receptor (ER)-negative breast carcinoma cells through suppression of nuclear factor kappa B activation.
Yousefi M; Ghaffari SH; Zekri A; Hassani S; Alimoghaddam K; Ghavamzadeh A
Arch Iran Med; 2014 May; 17(5):366-71. PubMed ID: 24784867
[TBL] [Abstract][Full Text] [Related]
9. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.
Kumar S; Raina K; Agarwal C; Agarwal R
Oncotarget; 2014 Jul; 5(13):4972-89. PubMed ID: 24970802
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle arrest and apoptogenic properties of opium alkaloids noscapine and papaverine on breast cancer stem cells.
Sajadian S; Vatankhah M; Majdzadeh M; Kouhsari SM; Ghahremani MH; Ostad SN
Toxicol Mech Methods; 2015; 25(5):388-95. PubMed ID: 25980655
[TBL] [Abstract][Full Text] [Related]
11. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.
Zi X; Feyes DK; Agarwal R
Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902
[TBL] [Abstract][Full Text] [Related]
12. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
13. Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells.
Zhang Y; Li Q; Ge Y; Chen Y; Chen J; Dong Y; Shi W
Phytother Res; 2013 Mar; 27(3):397-403. PubMed ID: 22619007
[TBL] [Abstract][Full Text] [Related]
14. The multidrug resistance pumps are inhibited by silibinin and apoptosis induced in K562 and KCL22 leukemia cell lines.
Noori-Daloii MR; Saffari M; Raoofian R; Yekaninejad M; Dinehkabodi OS; Noori-Daloii AR
Leuk Res; 2014 May; 38(5):575-80. PubMed ID: 24522246
[TBL] [Abstract][Full Text] [Related]
15. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells.
Bayram D; Çetin ES; Kara M; Özgöçmen M; Candan IA
Hum Exp Toxicol; 2017 Jun; 36(6):573-586. PubMed ID: 27402681
[TBL] [Abstract][Full Text] [Related]
16. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
Molavi O; Narimani F; Asiaee F; Sharifi S; Tarhriz V; Shayanfar A; Hejazi M; Lai R
Pharm Biol; 2017 Dec; 55(1):729-739. PubMed ID: 28027688
[TBL] [Abstract][Full Text] [Related]
17. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
[TBL] [Abstract][Full Text] [Related]
18. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
19. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
Dastpeyman M; Motamed N; Azadmanesh K; Mostafavi E; Kia V; Jahanian-Najafabadi A; Shokrgozar MA
Med Oncol; 2012 Dec; 29(4):2512-8. PubMed ID: 22101790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]